stoxline Quote Chart Rank Option Currency Glossary
  
Insulet Corporation (PODD)
165.48  1.06 (0.64%)    04-23 09:37
Open: 164.61
High: 165.535
Volume: 4,192
  
Pre. Close: 164.42
Low: 164.61
Market Cap: 11,587(M)
Technical analysis
2024-04-23 9:19:16 AM
Short term     
Mid term     
Targets 6-month :  202.07 1-year :  210.25
Resists First :  173 Second :  180
Pivot price 169.72
Supports First :  161.67 Second :  134.51
MAs MA(5) :  166.87 MA(20) :  169.23
MA(100) :  187.66 MA(250) :  212.21
MACD MACD :  -1.7 Signal :  -1.3
%K %D K(14,3) :  18.8 D(3) :  24.9
RSI RSI(14): 41.3
52-week High :  335.91 Low :  125.81
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ PODD ] has closed above bottom band by 26.6%. Bollinger Bands are 15.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 167.22 - 168.15 168.15 - 168.9
Low: 161.16 - 162.49 162.49 - 163.56
Close: 162.48 - 164.44 164.44 - 166.03
Company Description

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Headline News

Sun, 21 Apr 2024
abrdn plc Sells 11,574 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat

Sun, 14 Apr 2024
Insulet Corporation's (NASDAQ:PODD) Earnings Haven't Escaped The Attention Of Investors - Simply Wall St

Sun, 31 Mar 2024
Estimating The Fair Value Of Insulet Corporation (NASDAQ:PODD) - Simply Wall St

Tue, 19 Mar 2024
Here's Why Insulet (PODD) Detracted in Q4 - Yahoo Finance

Wed, 28 Feb 2024
Insulet (PODD) Q4 Earnings, Revenues Top Mark, Margins Expand - Yahoo Finance

Thu, 22 Feb 2024
Insulet Corp (PODD) Reports Robust Full Year and Q4 2023 Financial Results - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 70 (M)
Shares Float 70 (M)
Held by Insiders 0.3 (%)
Held by Institutions 103.5 (%)
Shares Short 3,120 (K)
Shares Short P.Month 2,680 (K)
Stock Financials
EPS 2.94
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 10.47
Profit Margin 12.1 %
Operating Margin 26 %
Return on Assets (ttm) 6 %
Return on Equity (ttm) 34.1 %
Qtrly Rev. Growth 37.9 %
Gross Profit (p.s.) 0
Sales Per Share 24.27
EBITDA (p.s.) 4.4
Qtrly Earnings Growth 504.2 %
Operating Cash Flow 146 (M)
Levered Free Cash Flow -38 (M)
Stock Valuations
PE Ratio 55.92
PEG Ratio 3
Price to Book value 15.68
Price to Sales 6.77
Price to Cash Flow 79.01
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android